Single-Photon Emission Computed Tomography/Computed Tomography in Abdominal Diseases

Seminars in Nuclear Medicine

Volumn 37, Issue 1, 2007, Pages 48-61

  Schillaci, Orazio ^a   Filippi, Luca ^a   Danieli, Roberta ^a   Simonetti, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ERYTHROCYTE TC 99M; GALLIUM 67; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; MACROSALB TC 99M; MEDRONATE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M; PHYTATE TC 99M; TECHNETIUM SULFUR COLLOID TC 99M; TECHNETIUM TIN COLLOID TC 99M;

ABDOMINAL DISEASE; ARTERY PERFUSION; BLOOD VESSEL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; ENTERITIS; GASTROINTESTINAL HEMORRHAGE; HEPATIC ARTERY; HUMAN; INTESTINE; LIVER HEMANGIOMA; LIVER PERFUSION; LIVER SCINTISCANNING; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLEEN; SPLEEN INJURY; SPLENECTOMY; SURGICAL PATIENT; TISSUE DISTRIBUTION;

ABDOMEN; CLINICAL TRIALS; GASTROINTESTINAL HEMORRHAGE; HEMANGIOMA; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER NEOPLASMS; RADIOGRAPHY, ABDOMINAL; SPLENOSIS; SUBTRACTION TECHNIQUE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33845195701     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2006.07.001     Document Type: Review

References (91)

1. Lucignani G. SPET: sustainable, powerful, effective, timely in vivo molecular imaging. Q J Nucl Med Mol Imaging 49 (2005) 117-120
2. Schillaci O. Functional-anatomical image fusion in neuroendocrine tumors. Cancer Biother Radiopharm 19 (2004) 129-134
3. Shreve P.D. Adding structure to function. J Nucl Med 41 (2000) 1380-1382
4. von Schulthess G.K. Integrated modality imaging with PET-CT and SPECT/CT: CT issues. Eur Radiol 15 suppl 4 (2005) D121-D126
5. Cook G.J.R., and Ott R.J. Dual-modality imaging. Eur Radiol 11 (2001) 1857-1858
6. von Schulthess G.K., and Pelc N.J. Integrated-modality imaging: the best of both words. Acad Radiol 9 (2002) 1241-1244
7. Israel O., Keidar Z., Iosilevsky G., et al. The fusion of anatomic and physiologic imaging in the management of patients with cancer. Semin Nucl Med 31 (2001) 191-205
8. Schillaci O., and Simonetti G. Fusion imaging in nuclear medicine-applications of dual-modality systems in oncology. Cancer Biother Radiopharm 19 (2004) 1-10
9. Schillaci O. Hybrid SPECT/CT: a new era for SPECT imaging?. Eur J Nucl Med Mol Imaging 32 (2005) 521-524
10. Choi B.Y., and Nguyen H.M. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 39 (2005) 401-412
11. Mergo P.J., and Ros P.R. Benign lesions of the liver. Radiol Clin North Am 36 (1998) 319-331
12. Federle M.P., and Brancatelli G. Imaging of benign hepatic masses. Semin Liver Dis 21 (2001) 237-249
13. Horton K.M., Bluemks D.A., Hruban R.H., et al. CT and MR imaging of benign hepatic and biliary tumors. Radiographics 19 (1999) 431-451
14. Trotter J.F., and Everson G.T. Benign focal lesions of the liver. Clin Liver Dis 5 (2001) 17-42
15. Kammula U.S., Buell J.F., Labow D.M., et al. Surgical management of benign tumors of the liver. Int J Gastrointest Cancer 30 (2001) 141-146
16. Jang H.J., Kim T.K., Lim H.K., et al. Hepatic hemangioma: atypical appearances on CT, MR imaging, and sonography. AJR Am J Roentgenol 180 (2003) 135-141
17. Yoon S.S., Charny C.K., Fong Y., et al. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 197 (2003) 392-402
18. Helmberger T.K., Laubenberger J., Rummeny E., et al. MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool. Eur Radiol 12 (2002) 62-70
19. Kim T., Federle M.P., Baron R.L., et al. Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology 219 (2001) 699-706
20. Kim T.K., Choi B.I., Han J.K., et al. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 216 (2000) 411-417
21. Royal H.D., Brown M.L., Drum D.E., et al. Procedure guideline for hepatic and splenic imaging. Society of Nuclear Medicine. J Nucl Med 39 (1998) 1114-1116
22. Ziessman H.A., Silverman P.M., Patterson J., et al. Improved detection of small cavernous hemangiomas of the liver with high resolution three-headed SPECT. J Nucl Med 32 (1991) 2086-2091
23. Scott A.M., Macapinlac H., Zhang J.J., et al. Clinical applications of fusion imaging in oncology. Nucl Med Biol 21 (1994) 775-784
24. Birnbaum B.A., Weinreb J.C., Megibow A.J., et al. Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT. Radiology 176 (1990) 95-101
25. Birnbaum B.A., Noz M.E., Chapnick J., et al. Hepatic hemangiomas: diagnosis with fusion of MR, CT, and Tc-99m-labeled red blood cell SPECT images. Radiology 181 (1991) 469-474
26. Front D., Israel O., Groshar O., et al. Technetium-99m-labeled red blood cell imaging. Semin Nucl Med 14 (1984) 226-250
27. Maquire Jr. G.Q., Noz M.E., Rusinek H., et al. Graphics applied to medical image registration. IEE Compute Graphic Appl 11 (1991) 20-28
28. Martinez-Lazaro R., Dominguez P., Pascau J., et al. Usefulness of Tc-99m RBC SPECT/MRI fusion imaging in small suspected hepatic hemangiomas. Clin Nucl Med 29 (2004) 844-845
29. Desco M., Lopez J., Benito C., et al. A multimodality workstation in practice. In: Lemke H.U., Vannier M.W., Inamura K., et al. (Eds). Computer Assisted Radiology and Surgery (CARS'99) (1999), Elsevier Science, Amsterdam 218-222
30. Hutton B.F., Braun M., Thurfjell L., et al. Image registration: an essential tool for nuclear medicine. Eur J Nucl Med Mol Imaging 29 (2002) 559-577
31. Patton J.A., Delbeke D., and Sandler M.P. Image fusion using an integrated-dual-head coincidence camera with x-ray tube-based attenuation maps. J Nucl Med 41 (2000) 1364-1368
32. Bocher M., Balan A., Krausz Y., et al. Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images. Eur J Nucl Med 27 (2000) 619-627
33. Schillaci O., Danieli R., Manni C., et al. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation?. Nucl Med Commun 25 (2004) 705-710
34. Schillaci O., Danieli R., Manni C., et al. Technetium-99m-labelled red blood cell imaging in the diagnosis of hepatic haemangiomas: the role of SPECT/CT with a hybrid camera. Eur J Nucl Med Mol Imaging 31 (2004) 1011-1015
35. Zheng J.G., Yao Z.M., Shu C.Y., et al. Role of SPECT/CT in diagnosis of hepatic hemangiomas. World J Gastroenterol 11 (2005) 5336-5341
36. Romer W., Fiedler E., Pavel M., et al. Attenuation correction of SPECT images based on separately performed CT: effect on the measurement of regional uptake values. Nuklearmedizin 44 (2005) 20-28
37. Brancatelli G., Vilgrain V., Zappa M., et al. Case 80: splenosis. Radiology 234 (2005) 1225-1229
38. Fleming C.R., Dickson E.R., and Harrison E.G. Splenosis: autotransplantation of splenic tissue. Am J Med 61 (1976) 414-419
39. Horger M., Eschmann S.M., Lengerke C., et al. Improved detection of splenosis in patients with haematological disorders: the role of combined transmission-emission tomography. Eur J Nucl Med Mol Imaging 30 (2003) 316-319
40. Livingstone C.D., Levine B.A., Lecklitner M.L., et al. Incidence and function of residual splenic tissue following splenectomy for trauma in adults. Arch Surg 118 (1983) 617-620
41. Wedemeyer J., Gratz K.F., Soudah B., et al. Splenosis-an important differential diagnosis in splenectomized patients presenting with abdominal masses of unknown origin. (in German). Z Gastroenterol 43 (2005) 1225-1229
42. Sikov W.M., Schiffman F.J., Weaver M., et al. Splenosis presenting as occult gastrointestinal bleeding. Am J Hematol 65 (2000) 56-61
43. Tsiotos G., and Schlinkert R.T. Laparoscopic splenectomy for immune thrombocytopenic purpura. Arch Surg 132 (1997) 642-646
44. Castellani M., Cappellini M.-D., Cappelletti M., et al. Tc-99m sulphur colloid scintigraphy in the assesment of residual splenic tissue after splenectomy. Clin Radiol 56 (2001) 596-598
45. Armas R.R. Clinical studies with spleen-specific radiolabeled agents. Semin Nucl Med 15 (1985) 260-275
46. Gunes I., Yilmazlar T., Sarikaya I., et al. Scintigraphic detection of splenosis: superiority of tomographic selective spleen scintigraphy. Clin Radiol 49 (1994) 115-117
47. Franceschetto A., Casolo A., Cuccia M., et al. Splenosis: Tc-99m-labelled colloids provide the diagnosis in splenectomised patients. Eur J Nucl Med Mol Imaging 33 (2006) 1102
48. Massey M.D., and Stevens J.S. Residual spleen found on denatured red blood cell scan following negative colloid scans. J Nucl Med 32 (1991) 2286-2287
49. Valdes Olmos R.A., Horenblas S., Kartachova M., et al. 99mTc-labelled heat-denatured erythrocyte SPET-CT matching to differentiate accessory spleen from tumour recurrence. Eur J Nucl Med Mol Imaging 31 (2004) 150
50. Clarkson B., Young C., Dierick W., et al. Effects of continuous hepatic artery infusion of antimetabolities on primary and metastatic cancer of the liver. Cancer 15 (1962) 472-488
51. Cohen A.D., and Kemeny N.E. An update on arterial infusion chemotherapy for colorectal cancer. Oncologist 8 (2003) 553-566
52. Lai Y.C., Shin C.Y., Jeng C.M., et al. Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with tumor thrombosis of the portal vein. World J Gastroenterol 9 (2003) 2666-2670
53. Barber F.D., Mavligit G., and Kurzrock R. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview. Cancer Treat Rev 30 (2004) 425-436
54. Schwartz J.D., and Beutler A.S. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma. Anticancer Drugs 15 (2004) 439-452
55. Kelly R.J., Kemeny N.E., and Leonard G.D. Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer. Clin Colorectal Cancer 5 (2005) 166-174
56. Seki H., Kimura M., Yoshimura N., et al. Development of extrahepatic arterial blood supply to the liver during hepatic arterial blood supply to the liver during hepatic arterial infusion chemotherapy. Eur Radiol 8 (1998) 1613-1618
57. Pozniak M.A., Bebel S.G., and Trump D.L. Complications of hepatic arterial infusion chemotherapy. RadioGraphics 3 (1991) 67-69
58. Hohn D.C., Stagg R.J., Price D.C., et al. Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2-deoxyurine. J Clin Oncol 3 (1985) 1257-1260
59. Pelosi E., Bar F., Battista S., et al. Hepatic arterial infusion chemotherapy for unresectable confined liver metastases: prediction of systemic toxicity with the application of a acintigraphic and pharmacokinetic approach. Cancer Chemother Pharmacol 44 (1999) 505-510
60. Lubin E., Cyjon A., and Neuman M. Technetium-99m macroaggregates for the study of the distribution of arterial infusion chemotherapy in the liver. Clin Nucl Med 12 (1987) 385-388
61. Bledin A.G., Kantarjian H.M., Kim E.E., et al. 99mTc-labeled macroaggregated albumin in intrahepatic arterial chemotherapy. AJR Am J Roentgenol 139 (1982) 711-715
62. Gyves J.W., Ziessman H.A., Ensminger W.D., et al. Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT). J Nucl Med 25 (1984) 972-977
63. Ziessman H.A., Wahl R.L., Juni J.E., et al. The utility of SPECT for 99mTc-MAA hepatic arterial perfusion scintigraphy. AJR Am J Roentgenol 145 (1985) 747-751
64. Seki H., Kimura M., Kamura T., et al. Hepatic perfusion abnormalities during treatment with hepatic arterial infusion chemotherapy: value of CT arteriography using an implantable port system. J Comput Assist Tomogr 20 (1996) 343-348
65. Denecke T., Hildebrandt B., Lehmkuhl L., et al. Fusion imaging using a hybrid SPECT/CT camera improves port perfusion scintigraphy for control of hepatic arterial infusion of chemotherapy in colorectal cancer patients. Eur J Nucl Med Mol Imaging 32 (2005) 103-1010
66. Ikeda O., Kusunoki S., Nakaura T., et al. Evaluation of fusion imaging using a combined spect/ct system; assessment of drug distribustion in patients whose catheter was fixed into a brunch of the hepatic aretry. (in Japanese). J Vasc Intervent Radiol 19 (2004) 393-397
67. Ikeda O., Kusunoki S., Nakaura T., et al. Comparison of fusion imaging using a combined SPECT/CT system and intra-arterial CT: assessment of drug distribution by an implantable port system in patients undergoing hepatic arterial infusion chemotherapy. Cardiovasc Intervent Radiol 29 (2006) 371-379
68. Martin-Comin J. Radiolabelled white blood cells in inflammatory bowel diseases. In: Signore A., Liberatore M., and Scopinaro F. (Eds). Nuclear medicine in the management of inflammatory and infectious diseases (2003), Springer-Verlag, Berlin Heidelberg 31-39
69. Gibson P., Lichtenstein M., Salehi N., et al. Values of positive technetium-99m leukocyte scans in predicting intestinal inflammation. Gut 32 (1991) 1502-1507
70. Lantto E., Jarvi K., Krekela I., et al. Technetium-99m hexamethyl propylene amine oxime leukocytes in the assessment of disease activity in inflammatory bowel disease. Eur J Nucl Med 19 (1992) 14-18
71. Roddie M.E., Peters A.M., and Danpure H.J. Inflammation: imaging with Tc-99m HMPAO-labelled leukocytes. Radiology 166 (1988) 767-772
72. Stahlberg D., Veress B., Mare K., et al. Leukocyte migration in acute colonic inflammatory bowel disease: comparison of histological assessment and Tc-99m-HMPAO labelled leukocyte scan. Am J Gastroenterol 92 (1997) 283-288
73. Weldon M.J., Joseph A.E.A., and Maxwell J.D. Single photon emission computerised tomography (SPECT):A novel technique for imaging inflammatory bowel disease. (abstr). Gut 33 (1992) S3
74. Weldon M.J., Masoomi A.M., Britten A.J., et al. Quantification of inflammatory bowel disease activity using technetium-99m HMPAO labelled leucocyte single photon emission computerised tomography (SPECT). Gut 36 (1995) 243-250
75. Charron M., del Rosario F.J., and Kochoshis S.A. Pediatric inflammatory bowel disease: assessment with scintigraphy with 99Tc white blood cells. Radiology 212 (1999) 507-513
76. Biancone L., Schillaci O., Capoccetti F., et al. Technetium-99m-HMPAO labeled leukocyte single photon emission computerized tomography (SPECT) for assessing Crohn's disease extent and intestinal infiltration. Am J Gastroenterol 100 (2005) 344-354
77. Biancone L., Scopinaro F., Ierardi M., et al. 99mTc-HMPAO granulocyte scintigraphy in the early detection of postoperative asymptomatic recurrence in Crohn's Disease. Dig Dis Sci 42 (1997) 1549-1556
78. Kaplan I.L., and Swayne L.C. Composite SPECT/CT images: technique and potential applications in chest and abdominal imaging. AJR Am J Roentgenol 152 (1999) 865-866
79. Swayne L.C. Computer-assisted fusion of single-photon emission tomographic and computed tomographic images. Evaluation in complicated inflammatory disease. Invest Radiol 27 (1992) 78-83
80. Mirtcheva R.M., Kostakoglu L., and Goldsmith S.J. SPECT+CT fusion imaging in 111In WBC scintigraphy. (abst). J Nucl Med 44 (2003) 341P-342P
81. Filippi L., Biancone L., and Petruzziello C. Tc-99m HMPAO labelled leukocyte scintigraphy with hybrid SPECT/CT detects perianal fistulas in Chron's disease. Clin Nucl Med 31 (2006) 541-542
82. Filippi L, Petruzziello C, Barone R, et al: Imaging Chron's disease by 99mTc-HMPAO-labeled leukocyte: usefulness of SPECT/CT with a hybrid camera. Eur J Nucl Med Mol Imaging (abstr) (in press)
83. Goerres G.W. SPECT/CT in non-malignant disease. In: von Schulthess G.K. (Ed). Clinical molecular anatomic imaging (2003), Lippincott Williams & Wilkins, Philadelphia 463-467
84. Winzelberg G.G., Froelich J.W., McKusick K.A., et al. Scintigraphic detection of gastrointestinal bleeding: a review of current methods. Am J Gastroenterol 78 (1983) 324-327
85. Howart D.M., Tang K., and Lees W. The clinical utility of nuclear medicine imaging for the detection of occult gastrointestinal haemorrhage. Nucl Med Commun 23 (2002) 591-594
86. Ford P.V., Bartold S.P., Fink-Bennett D.M., et al. Procedure guideline for gastrointestinal bleeding and Meckel's diverticulum scintigraphy. Society of Nuclear Medicine. J Nucl Med 40 (1999) 1226-1232
87. Zuckier L.S. Acute gastrointestinal bleeding. Semin Nucl Med 33 (2003) 297-311
88. Marignani M., Angeletti S., Filippi L., et al. Occult and obscure bleeding, iron deficiency anemia and other gastrointestinal stories. Int J Mol Med 15 (2005) 129-135
89. Howart D.M. The role of nuclear medicine in the detection of acute gastrointestinal bleeding. Semin Nucl Med 36 (2006) 133-146
90. Yama N., Ezoe E., Kimura Y., et al. Localization of intestinal bleeding using a fusion of Tc-99m-labeled RBC SPECT and x-ray CT. Clin Nucl Med 30 (2005) 488-489
91. Rosset A., Spadola L., and Ratib O. OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging 17 (2004) 205-216